Reply to 'Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?'
Assad ShitiIdit GoldfrachtNaim ShaheenStephanie ProtzeLior GepsteinPublished in: Nature communications (2021)
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- endothelial cells
- oral anticoagulants
- left atrial appendage
- induced pluripotent stem cells
- direct oral anticoagulants
- heart failure
- heart rate
- pluripotent stem cells
- high glucose
- percutaneous coronary intervention
- mitral valve
- blood pressure
- venous thromboembolism
- coronary artery disease